Clinical research studyDiabetes Prevalence and Therapeutic Target Achievement in the United States, 1999 to 2006
Section snippets
Study Design
NHANES is conducted by the National Center of Health Statistics, Centers for Disease Control and Prevention,15, 16 and uses a stratified, multistage probability sampling design. African Americans, Mexican Americans, and people aged 60 years or more are over-sampled to provide more reliable estimates of these subgroups. Written informed consent is obtained from all participants.
Sample and Data Collection
Our analysis included all men and nonpregnant women aged 20 years or more with valid data on their history of diabetes
Results
Table 1 shows the prevalence of diagnosed diabetes in NHANES during the period from 1999 to 2006. We pooled the data into two 4-year periods for comparison. The crude prevalence of diagnosed diabetes increased from 6.5% during the period from 1999 to 2002 to 7.8% from 2003 to 2006. After standardization to the United States 2000 population, the age-adjusted prevalence increased from 6.6% to 7.7%. Among subgroups, the increase was significant among women, non-Hispanic whites, and obese people.
Discussion
NHANES became a continuous survey program in 1999, and the data on the first 8 years have recently become available.15 This provides a good opportunity to study trends in the prevalence and control of diabetes in two 4-year periods. Combining data from 4 consecutive years evens out sampling biases and gives estimates that are more nationally representative and reliable.16 This is the first report of the latest control rates in adults with diagnosed diabetes during the period from 1999 to 2006.
Conclusions
From 1999 to 2006, the prevalence of diagnosed diabetes increased considerably; however, there was a significant improvement in the proportion of people with diagnosed diabetes achieving glycemic and cholesterol target levels. Nevertheless, only 1 in 8 people with diagnosed diabetes was able to achieve the recommended glycemic, blood pressure, and LDL cholesterol target levels at the same time. Diabetes remains a major challenge for the health profession in the United States.
References (40)
- et al.
Prevalence, treatment, and control of diagnosed diabetes in the U.S. National Health and Nutrition Examination Survey 1999-2004
Ann Epidemiol
(2008) Statins for people with diabetes
Lancet
(2008)- et al.
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
Lancet
(2004) - et al.
Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B
Am J Cardiol
(2004) - et al.
Accuracy of the ratio of triglycerides to high-density lipoprotein cholesterol for predicting low-density lipoprotein cholesterol particle sizes, phenotype B, and particle concentrations among Asian Indians
Am J Cardiol
(2006) - et al.
Thiazolidinediones for the treatment of type 2 diabetes
Eur J Intern Med
(2007) - et al.
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials
J Am Coll Cardiol
(2005) - et al.
Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002
Diabetes Care
(2006) - et al.
Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes
JAMA
(2004) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
N Engl J Med
(1993)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
N Engl J Med
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
BMJ
Diabetic nephropathy: diagnosis, prevention, and treatment
Diabetes Care
Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial
JAMA
Standards of Medical Care in Diabetes-2008
Diabetes Care
Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report
Diabetes Care
Is glycemic control improving in U.S. adults?
Diabetes Care
Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002
Ann Intern Med
National Health and Nutrition Examination Survey data sets and related documentation (Survey Questionnaire, Examination and Laboratory Protocols, 1999-2006)
The National Health and Nutrition Examination Survey (NHANES) Analytic and Reporting Guidelines
Cited by (318)
Inadequate achievement of ABC goals (HbA1c, blood pressure, LDL-C) among patients with type 2 diabetes in an Iranian population, 2012–2017
2020, Diabetes and Metabolic Syndrome: Clinical Research and ReviewsCitation Excerpt :Between 1999 and 2002, 36% of individuals achieved LDL-C of <100 mg/dL, while in the period from 2003 to 2006 this number increased to 46%. Merely 7% of patients in 1999–2002 and 12% in 2003–2006 had achieved all three ABC goals [12]. The evidence that is available to control serum LDL-C levels is related to clinical trials of statin therapy which indicates that the importance of treatment with statins has been considerably appreciated during the last decade which is admirable [13].
Prevalence and correlation of glycemic control achievement in patients with type 2 diabetes in Iraq: A retrospective analysis of a tertiary care database over a 9-year period
2020, Diabetes and Metabolic Syndrome: Clinical Research and ReviewsFactors associated with therapeutic target achievement in the control of complications in consequence of diabetes: A hospital-based study in west of Iran
2019, Diabetes and Metabolic Syndrome: Clinical Research and Reviews
Funding: K. L. Ong is a recipient of a University of Hong Kong Postgraduate Fellowship (2007-2008).
Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.
Authorship: All authors had access to the data and played a role in writing this manuscript.